Quantcast
Last updated on June 19, 2013 at 15:13 EDT

Latest C. albicans Stories

2012-11-16 16:23:54

Bonita Springs, Fla., Nov. 16, 2012 /PRNewswire-iReach/ -- VR Laboratories LLC today announced they have selected a lead product candidate based on preclinical activity to target Candida albicans (C. albicans). C. albicans is the most common yeast species that causes candidiasis, commonly referred to as yeast infections. Candidiasis includes topical infections such as thrush as well as systemic and potentially life-threatening invasive diseases. (Photo:...